These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 15703837
21. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Subhashini J, Mahipal SV, Reddanna P. Cancer Lett; 2005 Jun 16; 224(1):31-43. PubMed ID: 15911099 [Abstract] [Full Text] [Related]
22. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Cavazos DA, Price RS, Apte SS, deGraffenried LA. Prostate; 2011 Sep 15; 71(13):1420-8. PubMed ID: 21360560 [Abstract] [Full Text] [Related]
23. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV. Cancer Res; 2006 Apr 15; 66(8):4542-6. PubMed ID: 16618783 [Abstract] [Full Text] [Related]
24. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid]. Yi L, Zhang QY, Mi MT. Ai Zheng; 2007 Dec 15; 26(12):1281-6. PubMed ID: 18076787 [Abstract] [Full Text] [Related]
25. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents. Mehar A, Macanas-Pirard P, Mizokami A, Takahashi Y, Kass GE, Coley HM. J Pharmacol Exp Ther; 2008 Mar 15; 324(3):1181-7. PubMed ID: 18089846 [Abstract] [Full Text] [Related]
26. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR]. Zheng WB, Wang CH, Qiang O, Tang CW. Ai Zheng; 2004 Dec 15; 23(12):1628-32. PubMed ID: 15601550 [Abstract] [Full Text] [Related]
27. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3]. Xu S, Zhou WQ, Zhang ZY, Ge JP, Gao JP. Zhonghua Nan Ke Xue; 2008 Jun 15; 14(6):489-93. PubMed ID: 18649743 [Abstract] [Full Text] [Related]
28. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Swamy MV, Cooma I, Patlolla JM, Simi B, Reddy BS, Rao CV. Mol Cancer Ther; 2004 Feb 15; 3(2):215-21. PubMed ID: 14985462 [Abstract] [Full Text] [Related]
29. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Kim SH, Hwang CI, Juhnn YS, Lee JH, Park WY, Song YS. Carcinogenesis; 2007 Jan 15; 28(1):223-31. PubMed ID: 17166886 [Abstract] [Full Text] [Related]
30. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells. Horia E, Watkins BA. Carcinogenesis; 2007 Apr 15; 28(4):809-15. PubMed ID: 17052999 [Abstract] [Full Text] [Related]
31. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment. Wagner M, Loos J, Weksler N, Gantner M, Corless CL, Barry JM, Beer TM, Garzotto M. Biochem Biophys Res Commun; 2005 Jul 08; 332(3):800-7. PubMed ID: 15907789 [Abstract] [Full Text] [Related]
32. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib. Narayanan NK, Nargi D, Horton L, Reddy BS, Bosland MC, Narayanan BA. Prostate; 2009 Feb 01; 69(2):133-41. PubMed ID: 18819100 [Abstract] [Full Text] [Related]
33. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth. Bozzo F, Bassignana A, Lazzarato L, Boschi D, Gasco A, Bocca C, Miglietta A. Chem Biol Interact; 2009 Dec 10; 182(2-3):183-90. PubMed ID: 19682443 [Abstract] [Full Text] [Related]
34. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W, Yu CH, Hu KQ. Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255 [Abstract] [Full Text] [Related]
35. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B, Shi ZL, Feng J, Tao HM. Cell Biol Int; 2008 May 15; 32(5):494-501. PubMed ID: 18078766 [Abstract] [Full Text] [Related]
36. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways. Ogunwobi OO, Beales IL. Regul Pept; 2006 Mar 15; 134(1):1-8. PubMed ID: 16169610 [Abstract] [Full Text] [Related]
37. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Lin J, Hsiao PW, Chiu TH, Chao JI. Biochem Pharmacol; 2005 Sep 01; 70(5):658-67. PubMed ID: 16004971 [Abstract] [Full Text] [Related]
38. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Reddy BS. Environ Mol Mutagen; 2004 Sep 01; 44(1):26-35. PubMed ID: 15199544 [Abstract] [Full Text] [Related]
39. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE. Biotech Histochem; 2013 Jan 01; 88(1):38-46. PubMed ID: 23167625 [Abstract] [Full Text] [Related]
40. Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells. Narayanan NK, Narayanan BA, Bosland M, Condon MS, Nargi D. Int J Cancer; 2006 Oct 01; 119(7):1586-98. PubMed ID: 16646082 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]